SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-345607
Filing Date
2012-08-09
Accepted
2012-08-09 08:01:56
Documents
3
Period of Report
2012-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d392522d8k.htm 8-K 14944
2 SAGENT PHARMACEUTICALS, INC. PRESS RELEASE, DATED AUGUST 9, 2012 d392522dex991.htm EX-99.1 122049
3 GRAPHIC g392522g85x99.jpg GRAPHIC 26974
  Complete submission text file 0001193125-12-345607.txt   175601
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-35144 | Film No.: 121018556
SIC: 2834 Pharmaceutical Preparations